Dale Farkas

664 total citations
34 papers, 521 citations indexed

About

Dale Farkas is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Food Science. According to data from OpenAlex, Dale Farkas has authored 34 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 12 papers in Electrical and Electronic Engineering and 8 papers in Food Science. Recurrent topics in Dale Farkas's work include Inhalation and Respiratory Drug Delivery (29 papers), Aerosol Filtration and Electrostatic Precipitation (12 papers) and Neonatal Respiratory Health Research (10 papers). Dale Farkas is often cited by papers focused on Inhalation and Respiratory Drug Delivery (29 papers), Aerosol Filtration and Electrostatic Precipitation (12 papers) and Neonatal Respiratory Health Research (10 papers). Dale Farkas collaborates with scholars based in United States and Australia. Dale Farkas's co-authors include P. Worth Longest, Michael Hindle, Amr Hassan, Karl Bass, Mohammad A. M. Momin, Laleh Golshahi, Geng Tian, Connor A. Howe, Arun V. Kolanjiyil and Ross Walenga and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Dale Farkas

31 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale Farkas United States 16 472 134 117 74 58 34 521
Landon T. Holbrook United States 8 335 0.7× 136 1.0× 55 0.5× 63 0.9× 35 0.6× 12 423
Yoen‐Ju Son United States 15 645 1.4× 111 0.8× 175 1.5× 43 0.6× 225 3.9× 19 717
Renishkumar Delvadia United States 14 545 1.2× 171 1.3× 79 0.7× 70 0.9× 100 1.7× 17 612
Michiel Van Oort United States 7 334 0.7× 102 0.8× 123 1.1× 43 0.6× 91 1.6× 8 380
Doetie Gjaltema Netherlands 11 594 1.3× 148 1.1× 162 1.4× 91 1.2× 107 1.8× 15 637
Karl Bass United States 11 272 0.6× 98 0.7× 28 0.2× 62 0.8× 18 0.3× 13 304
P.K.P. Burnell United Kingdom 8 484 1.0× 136 1.0× 40 0.3× 45 0.6× 27 0.5× 11 516
Jinxiang Xi United States 13 280 0.6× 44 0.3× 26 0.2× 43 0.6× 58 1.0× 40 446
G. Brambilla Italy 11 439 0.9× 78 0.6× 73 0.6× 29 0.4× 57 1.0× 19 469
J. Goede Netherlands 7 314 0.7× 92 0.7× 128 1.1× 73 1.0× 75 1.3× 10 357

Countries citing papers authored by Dale Farkas

Since Specialization
Citations

This map shows the geographic impact of Dale Farkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale Farkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale Farkas more than expected).

Fields of papers citing papers by Dale Farkas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale Farkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale Farkas. The network helps show where Dale Farkas may publish in the future.

Co-authorship network of co-authors of Dale Farkas

This figure shows the co-authorship network connecting the top 25 collaborators of Dale Farkas. A scholar is included among the top collaborators of Dale Farkas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale Farkas. Dale Farkas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jubaer, Hasan, Dale Farkas, Mohammad A. M. Momin, et al.. (2025). Development of CPAP Overlay Interfaces for Efficient Administration of Aerosol Surfactant Therapy to Preterm Infants. AAPS PharmSciTech. 26(1). 34–34. 1 indexed citations
2.
3.
Longest, P. Worth, Michael Hindle, Dale Farkas, et al.. (2025). Preclinical Testing of a New Dry Powder Aerosol Synthetic Lung Surfactant Formulation and Device Combination for the Treatment of Neonatal Respiratory Distress Syndrome. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 38(4). 168–191.
4.
Pangeni, Rudra, Mohammad A. M. Momin, Dale Farkas, et al.. (2024). Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection. International Journal of Pharmaceutics. 662. 124504–124504.
5.
Momin, Mohammad A. M., Dale Farkas, Michael Hindle, et al.. (2024). Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization. Pharmaceutical Research. 41(8). 1703–1723. 4 indexed citations
6.
Momin, Mohammad A. M., et al.. (2023). Effects of different mesh nebulizer sources on the dispersion of powder formulations produced with a new small-particle spray dryer. International Journal of Pharmaceutics. 642. 123138–123138. 6 indexed citations
7.
Pangeni, Rudra, Amr Hassan, Dale Farkas, et al.. (2023). New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats. Molecular Pharmaceutics. 20(4). 2207–2216. 4 indexed citations
8.
Jubaer, Hasan, Dale Farkas, Arun V. Kolanjiyil, et al.. (2023). Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels. Journal of Aerosol Science. 175. 106262–106262. 7 indexed citations
9.
10.
11.
Hassan, Amr, Dale Farkas, P. Worth Longest, & Michael Hindle. (2020). Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations. International Journal of Pharmaceutics. 591. 120027–120027. 20 indexed citations
12.
Bass, Karl, et al.. (2020). High-efficiency dry powder aerosol delivery to children: Review and application of new technologies. Journal of Aerosol Science. 153. 105692–105692. 23 indexed citations
13.
14.
Longest, P. Worth, Dale Farkas, Amr Hassan, & Michael Hindle. (2020). Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance. Pharmaceutical Research. 37(6). 101–101. 27 indexed citations
15.
Farkas, Dale, et al.. (2019). Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(2). 83–98. 18 indexed citations
16.
Farkas, Dale, Michael Hindle, & P. Worth Longest. (2017). Development of an Inline Dry Powder Inhaler That Requires Low Air Volume. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(4). 255–265. 27 indexed citations
17.
Traini, Daniela, et al.. (2017). The Development and Validation of an In Vitro Airway Model to Assess Realistic Airway Deposition and Drug Permeation Behavior of Orally Inhaled Products Across Synthetic Membranes. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(2). 103–108. 5 indexed citations
18.
Longest, P. Worth, et al.. (2014). Development of high efficiency ventilation bag actuated dry powder inhalers. International Journal of Pharmaceutics. 465(1-2). 52–62. 19 indexed citations
19.
Longest, P. Worth, et al.. (2014). Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(3). 189–201. 33 indexed citations
20.
Longest, P. Worth, et al.. (2013). Development and Comparison of New High-Efficiency Dry Powder Inhalers for Carrier-Free Formulations. Journal of Pharmaceutical Sciences. 103(2). 465–477. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Landon T. Holbrook Breakdown of academic impact, for papers by Yoen‐Ju Son Breakdown of academic impact, for papers by Renishkumar Delvadia Breakdown of academic impact, for papers by Michiel Van Oort Breakdown of academic impact, for papers by Doetie Gjaltema Breakdown of academic impact, for papers by Karl Bass Breakdown of academic impact, for papers by P.K.P. Burnell Breakdown of academic impact, for papers by Jinxiang Xi Breakdown of academic impact, for papers by G. Brambilla Breakdown of academic impact, for papers by J. Goede
Rankless by CCL
2026